Persistent angiotensin and inflammatory dysregulation are associated with poor outcomes in COVID-19-associated ischemic stroke

Key Points

• Poor outcomes in COVID-19-associated ischemic stroke are linked to inflammatory dysregulation.
• Markers of angiotensin and inflammation could help predict stroke severity in patients.
• Observational analysis assessed biomarkers in patients with ischemic stroke related to COVID-19.
• Highlights the need for targeted interventions to manage inflammation in affected individuals.